van der Pol MA - Search Results

1

Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burden.

Feller N, Jansen-van der Weide MC, van der Pol MA, Westra GA, Ossenkoppele GJ, Schuurhuis GJ. Feller N, et al. Among authors: van der pol ma. Exp Hematol. 2005 Jan;33(1):120-30. doi: 10.1016/j.exphem.2004.10.007. Exp Hematol. 2005. PMID: 15661405 Free article. Clinical Trial.

2

Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.

van der Pol MA, Broxterman HJ, Pater JM, Feller N, van der Maas M, Weijers GW, Scheffer GL, Allen JD, Scheper RJ, van Loevezijn A, Ossenkoppele GJ, Schuurhuis GJ. van der Pol MA, et al. Among authors: van der maas m, van loevezijn a. Haematologica. 2003 Feb;88(2):134-47. Haematologica. 2003. PMID: 12604403

3

Assessment of the normal or leukemic nature of CD34+ cells in acute myeloid leukemia with low percentages of CD34 cells.

van der Pol MA, Feller N, Roseboom M, Moshaver B, Westra G, Broxterman HJ, Ossenkoppele GJ, Schuurhuis GJ. van der Pol MA, et al. Haematologica. 2003 Sep;88(9):983-93. Haematologica. 2003. PMID: 12969806

4

Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.

Feller N, van der Pol MA, Waaijman T, Weijers GW, Westra G, Ossenkoppele GJ, Schuurhuis GJ. Feller N, et al. Among authors: van der pol ma. Clin Cancer Res. 2005 Jul 1;11(13):4793-801. doi: 10.1158/1078-0432.CCR-05-0031. Clin Cancer Res. 2005. PMID: 16000576 Free article. Clinical Trial.

5

High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival.

van Rhenen A, Feller N, Kelder A, Westra AH, Rombouts E, Zweegman S, van der Pol MA, Waisfisz Q, Ossenkoppele GJ, Schuurhuis GJ. van Rhenen A, et al. Among authors: van der pol ma. Clin Cancer Res. 2005 Sep 15;11(18):6520-7. doi: 10.1158/1078-0432.CCR-05-0468. Clin Cancer Res. 2005. PMID: 16166428 Free article.

6

Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemia.

van der Pol MA, Pater JM, Feller N, Westra AH, van Stijn A, Ossenkoppele GJ, Broxterman HJ, Schuurhuis GJ. van der Pol MA, et al. Among authors: van stijn a. Leukemia. 2001 Oct;15(10):1554-63. doi: 10.1038/sj.leu.2402245. Leukemia. 2001. PMID: 11587213

7

High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome.

Feller N, Schuurhuis GJ, van der Pol MA, Westra G, Weijers GW, van Stijn A, Huijgens PC, Ossenkoppele GJ. Feller N, et al. Among authors: van stijn a, van der pol ma. Leukemia. 2003 Jan;17(1):68-75. doi: 10.1038/sj.leu.2402781. Leukemia. 2003. PMID: 12529662 Clinical Trial.

8

A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia.

van Stijn A, Kok A, van der Pol MA, Feller N, Roemen GM, Westra AH, Ossenkoppele GJ, Schuurhuis GJ. van Stijn A, et al. Among authors: van der pol ma. Leukemia. 2003 Apr;17(4):780-6. doi: 10.1038/sj.leu.2402885. Leukemia. 2003. PMID: 12682637

9

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia.

Feller N, van der Pol MA, van Stijn A, Weijers GW, Westra AH, Evertse BW, Ossenkoppele GJ, Schuurhuis GJ. Feller N, et al. Among authors: van der pol ma. Leukemia. 2004 Aug;18(8):1380-90. doi: 10.1038/sj.leu.2403405. Leukemia. 2004. PMID: 15201848

10

Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.

Moshaver B, van Rhenen A, Kelder A, van der Pol M, Terwijn M, Bachas C, Westra AH, Ossenkoppele GJ, Zweegman S, Schuurhuis GJ. Moshaver B, et al. Stem Cells. 2008 Dec;26(12):3059-67. doi: 10.1634/stemcells.2007-0861. Stem Cells. 2008. PMID: 19096043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters